OctoPlus uses its proprietary drug delivery technologies to develop controlled release products for clients

We engage in new product opportunities with partners that provide an active ingredient that may be improved by combining it with our drug delivery technologies.

We are flexible in forming partnerships to develop improved therapeutic formulations. We are currently performing feasibility studies for a number of clients in which the combination of our technology with the client's therapeutic ingredient is evaluated.

A number of products based on our controlled release technology is now available for licensing.

If you're interested in more information about our technologies or about licensing opportunities, please contact our business development department.